Kidney Disease

View All

Chimeric antigen receptor T cell (CART) Treatment
With early-stage data, Chimeric antigen receptor T cell (CART) finding its way towards entering Prostate and Kidney Cancer market

Use of CAR-T treatments and their efficacy in Prostate Cancer We already know that Immunotherapies have not performed well in the treatment of prostate cancer. Such medicines have failed to elicit a long-term response in patients with advanced prostate cancer. Surgery, radiation treatment, chemotherapy, androgen...

Find More

key-cardiovascular-disease-risk-factors
Rising Global Prevalence of Cardiovascular Diseases And Top Players In Cardiology

Cardiovascular Diseases (CVDs), primarily constituting heart failure, ischemic heart disease, stroke, are considered as leading global cause of mortality and a major contributor to disability. Over the last 30 years, deaths and disabilities from Cardiovascular Disease have been steadily rising across the globe. Car...

Find More

Invokana matches; Xultophy beats; Lilly and BI follow; Tresiba matches

J&J's Invokana matches Jardiance's 14% reduction in major CV events There’s officially another heart-helping SGLT2 on the block. But this one brings some varied benefits—and amputation risks—along with it. In a cardiovascular outcomes trial, Johnson & Johnson's Invokana matched up to Eli Lilly and Boehringer...

Find More